Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ANIP | CLUSTER | neutral | 3/10 | Three ANIP insiders, including the CEO and General Counsel, sold a total of ~$490K in open-market sales over a one-week | Sep 15, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | CEO Martine Rothblatt executed a large cluster of open-market sales totaling ~$6.7M over Sept 10-11, 2026, following a $ | Sep 15, 2026 |
| CORT | CLUSTER | bearish | 4/10 | Two Corcept Therapeutics insiders sold a combined $1.64M in open-market sales over two days, with no indication of 10b5- | Sep 15, 2026 |
| GILD | CLUSTER | neutral | 3/10 | Two GILD executives (CFO Dickinson and CCO Mercier) sold a combined $523K in open-market sales on September 15, 2026, wh | Sep 15, 2026 |
| CORT | CLUSTER | bearish | 4/10 | Two Corcept Therapeutics insiders (a director and a senior officer) sold a combined $1.64M in open-market sales over a 3 | Sep 15, 2026 |
| GILD | CLUSTER | neutral | 2/10 | Gilead Sciences CFO and Chief Communications Officer executed open-market sales totaling $523K on September 15, 2026, fo | Sep 15, 2026 |
| ORKA | CLUSTER | neutral | 3/10 | Three Oruka insiders (CEO, COO, SVP Finance) sold a combined $375,574.92 in open-market sales on 2026-09-15. The cluster | Sep 15, 2026 |
| NBIX | CLUSTER | neutral | 3/10 | Insider cluster shows 2 insiders with open-market sales totaling $493K (CFO Abernethy sold 2,311 shares for $363K; anoth | Sep 15, 2026 |
| KRRO | CLUSTER | neutral | 2/10 | Insider cluster: 2 insiders sold a total of $450K in KRRO over the past 7 days. The most recent transaction is a single | Sep 15, 2026 |
| PHVS | CLUSTER | bearish | 5/10 | Four Pharvaris insiders, including the CEO and President, sold a total of $2.15M in open-market shares over a 7-day wind | Sep 15, 2026 |
| MAIA | CLUSTER | bullish | 6/10 | CEO Vlad Vitoc and Director Ramiro Guerrero collectively purchased $150K of MAIA stock in open-market transactions over | Sep 15, 2026 |
| AMLX | CLUSTER | mixed | 4/10 | Two C-suite insiders at Amylyx (CFO and CMO) sold a combined ~$103K in open-market sales on September 10, 2026, just two | Sep 15, 2026 |
| ARTV | CLUSTER | neutral | 4/10 | Four Artiva Biotherapeutics insiders, including the CEO, COO, CTO, and CMO, sold a total of $477K in open-market shares | Sep 15, 2026 |
| ARTV | CLUSTER | neutral | 3/10 | Four Artiva Biotherapeutics insiders, including the CEO, COO, and CTO, sold a total of ~$477K in open-market shares over | Sep 14, 2026 |
| ANIP | CLUSTER | neutral | 2/10 | Two ANIP insiders — a director and the SVP/General Counsel — sold a combined $107K in open-market transactions over a 4- | Sep 14, 2026 |
| RVMD | CLUSTER | neutral | 3/10 | Two insiders at Revolution Medicines executed a cluster of open-market sales totaling ~$6.5M over three days, with the b | Sep 14, 2026 |
| ARTV | CLUSTER | neutral | 4/10 | A cluster of insider selling at Artiva Biotherapeutics (ARTV) totaling $477K over the past week, led by CEO Fred Aslan ( | Sep 14, 2026 |
| JAZZ | CLUSTER | neutral | 3/10 | Two Jazz Pharmaceuticals insiders, including the President & CEO and EVP & Chief Legal Officer, sold a combined $775K in | Sep 14, 2026 |
| LGND | CLUSTER | neutral | 3/10 | Two insiders at Ligand Pharmaceuticals sold a combined $427K in open-market transactions over a one-week window. The sal | Sep 14, 2026 |
| PHVS | CLUSTER | neutral | 3/10 | Pharvaris N.V. (PHVS) — insider cluster of 3 sells totaling $2.06M over the last 7 days, led by Chief Early Development | Sep 14, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | CEO Martine Rothblatt sold ~$6.9M in open-market shares on Sep 9-10, 2026, while simultaneously exercising stock options | Sep 12, 2026 |
| ARTV | CLUSTER | neutral | 3/10 | A cluster of insider selling at Artiva Biotherapeutics, totaling $477K, was driven by the CEO, COO, CTO, and CMO. The CE | Sep 11, 2026 |
| CYTK | CLUSTER | neutral | 2/10 | Two insiders at Cytokinetics sold a combined $339K in open-market sales over a week. The EVP of R&D exercised and immedi | Sep 11, 2026 |
| PHVS | CLUSTER | neutral | 3/10 | Two Pharvaris insiders, including President Lu Peng, sold a combined $911K in open-market sales this week. The sales fol | Sep 11, 2026 |
| RLMD | CLUSTER | bullish | 6/10 | RLMD CEO Sergio Traversa and CFO Maged Shenouda collectively purchased $1.67M of stock in open-market transactions over | Sep 11, 2026 |
| GRCE | CLUSTER | bullish | 6/10 | Two insiders at Grace Therapeutics, including the CEO and a 10% owner, made open-market purchases totaling $226K in a 7- | Sep 11, 2026 |
| JAZZ | CLUSTER | neutral | 2/10 | A small insider selling cluster at Jazz Pharmaceuticals, with the CEO and a director selling a combined ~$2M in open-mar | Sep 11, 2026 |
| UTHR | CLUSTER | mixed | 4/10 | CEO Martine Rothblatt sold ~$5.9M of UTHR stock over two days (Sep 8-9), including shares acquired via option exercises | Sep 11, 2026 |
| INBX | CLUSTER | bullish | 7/10 | CEO Mark Lappe made a large open-market purchase cluster totaling ~$2.6M across six trades on September 8, 2026, alongsi | Sep 10, 2026 |
| RXRX | CLUSTER | neutral | 2/10 | CEO Najat Khan and Director Blake Borgeson sold a combined $179K in open-market RXRX shares over a one-week window. The | Sep 10, 2026 |